for the open and 121 min (89-187)/11 days (5-18) for the laparoscopic procedure (including conversion) (p<0.5 in both comparisons). Pancreatic fistula rate was respectively 28.57% (2/7) and 20% (1/5) (p=0.65). Mortality was nil. Mean follow-up was 54 months (3-109). Recurrent hypoglycemia was documented in one patient of the laparoscopic group (p=0.46) but blood glucose concentrations remained stable with diazoxide. Conclusion Laparoscopic insulinoma enucleation seems to be a feasible and safe approach associated with reduction in hospital stay and comparable rates of pancreatic fistula in relation to open surgery.
